#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15370	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2525	751.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1639	1639	C	958	C,T,A	955,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25804	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4074	789.9	0	.	n	.	0	T695C	SNP	695	695	T	1299	1299	C	969	C,T,A,G	965,1,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25804	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4074	789.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1941	1941	A	1075	A,G,C	1073,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25804	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4074	789.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2575	2575	C	898	C,G,A	896,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25804	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4074	789.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3201	3201	T	846	T,C,G	841,1,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25804	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4074	789.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2649	2649	A	839	A,T,G	837,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2136	folP	855	855	100.0	folP.l15.c4.ctg.1	1886	141.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1197	1199	AGC	219;219;217	A,G;G;C	218,1;219;217	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5460	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3798	179.2	1	SNP	p	S91F	1	.	.	271	273	TTC	770	772	TTC	193;193;192	T;T;C	193;193;192	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5460	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3798	179.2	1	SNP	p	G95N	0	.	.	283	285	GGC	782	784	GGC	203;203;203	G;G,A;C	203;202,1;203	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5460	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3798	179.2	1	SNP	p	D95G	1	.	.	283	285	GGC	782	784	GGC	203;203;203	G;G,A;C	203;202,1;203	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2124	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1801	147.0	1	SNP	p	G45D	0	.	.	133	135	GGC	689	691	GGC	266;265;266	G;G;C	266;265;266	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1140	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1443	98.6	0	.	n	.	0	A197.	DEL	197	197	A	793	793	A	217	A,G,C	215,1,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3375	199.2	1	SNP	p	D86N	0	.	.	256	258	GAC	859	861	GAC	224;224;226	G;A,G;C	224;223,1;226	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3375	199.2	1	SNP	p	R87W	0	.	.	259	261	CGT	862	864	CGT	225;223;219	C;G;T	225;223;219	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3375	199.2	1	SNP	p	S87R	1	.	.	259	261	CGT	862	864	CGT	225;223;219	C;G;T	225;223;219	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3375	199.2	1	SNP	p	R87I	0	.	.	259	261	CGT	862	864	CGT	225;223;219	C;G;T	225;223;219	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5394	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3375	199.2	1	SNP	p	S88P	0	.	.	262	264	TCC	865	867	TCC	221;224;225	T;C;C,T	220;224;224,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4378	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3115	175.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1797	1799	GGC	248;251;247	G;G;C	248;251;247	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1466	1468	GCA	246;245;245	G;C,A;A	246;244,1;245	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1469	1471	ATC	245;247;245	A,C;T;C,T	243,2;247;244,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1481	1483	GTG	248;250;249	G;T;G,A	248;250;247,2	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1481	1483	GTG	248;250;249	G;T;G,A	248;250;247,2	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1985	1987	ACC	257;257;255	A;C,T;C	257;256,1;255	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2039	2041	GCG	242;239;240	G;C;G	242;239;240	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2039	2041	GCG	242;239;240	G;C;G	242;239;240	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2162	2164	AGC	199;198;196	A;G;C	199;198;196	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2171	2173	GGC	191;188;186	G;G;C	191;188;186	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4160	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2906	178.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2189	2191	CCG	193;195;198	C,G,A;C;G,T	188,3,2;195;197,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5640	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3522	199.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1860	1862	CCG	257;255;255	C,A;C,A;G	256,1;254,1;255	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2770	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2295	150.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	782	782	C	209	C	209	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	21;26;27	T;T;A	21;26;27	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	65;65;65	C;A;T	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	65;65;65	A;G;T	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	65;65;65	T;A;C	65;65;65	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	3;3;3	G;A;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T,C;C	3;2,1;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	226	90.27	porB1a.l15.c4.ctg.1	588	22.3	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	100	94.0	porB1a.l15.c4.ctg.2	182	52.9	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	55;55;52	A;C;G	55;55;52	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	512	312	porB1a	984	100	94.0	porB1a.l15.c4.ctg.2	182	52.9	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	17;16;15	C;A;A	17;16;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	600	602	GAA	243;243;244	G,T;A;A	242,1;243;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	.	MULTIPLE	358	359	AA	845	846	CG	216;214	C;G	216;214	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	.	MULTIPLE	361	362	GA	848	850	CAG	214;214;216	C;A;G	214;214;216	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	N122K	NONSYN	364	366	AAC	852	854	AAA	218;219;221	A,C;A;A	217,1;219;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	879	881	TAT	243;242;246	T;A;T	243;242;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	N134E	NONSYN	400	402	AAT	888	890	GAG	240;242;239	G;A;G	240;242;239	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	V135F	NONSYN	403	405	GTG	891	893	TTT	243;242;242	T,A;T;T,C	241,2;242;241,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	G140K	NONSYN	418	420	GGA	906	908	AAA	250;251;251	A;A,C;A	250;250,1;251	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1011	1013	TCA	222;223;223	T,C;C;A,C	221,1;223;222,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1140	1142	GTC	234;236;238	G;T,G;C	234;235,1;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1470	1472	GCA	235;238;240	G,A;C;A	234,1;238;240	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	1	SNP	p	G120K	1	.	.	358	360	AAG	845	847	CGG	216;214;214	C;G;G	216;214;214	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	1	SNP	p	D121N	0	.	.	361	363	GAC	848	851	CGC	214;216;213	C;G;C,G	214;216;212,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2924	porB1b	1047	1047	98.19	porB1b.l6.c4.ctg.1	1939	187.4	1	SNP	p	A121D	1	.	.	361	363	GAC	848	851	CGC	214;216;213	C;G;C,G	214;216;212,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10354	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5155	250.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1508	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1433	131.1	1	SNP	p	V57M	1	.	.	169	171	ATG	795	797	ATG	257;258;260	A;T;G	257;258;260	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
